Search





Search





News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Presentations

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

Transcripts

Rand Capital (RAND) Fiscal Q3 2026 Earnings Call: Interest Income Improves, NAV Rises

Rand Capital fiscal Q3 2026 earnings call: portfolio interest income rose 4% sequentially, NAV reached $17.36, while non-accruals weighed on income.

Rand Capital Corp

TradingKey

Wed, Nov 4

Economic Indicator

Hong Kong: Growth outlook improves – UOB

UOB economist Ho Woei Chen reports that Hong Kong’s Gross Domestic Product (GDP) growth accelerated sharply in 3Q26, driven by strong goods exports and investment. Chen highlights support from the semiconductors and AI supply chain, a stabilising property market and rising tourist arrivals. UOB revises its Hong Kong GDP forecasts higher for 2026 and 2027, while flagging external and financial risks.

Fxstreet

Wed, Nov 4

Transcripts

JELD-WEN (JELD) Q3 2026 Earnings Call: Guidance Held as Demand Softens

JELD-WEN Q3 2026 revenue fell 1% to $799 million, adjusted EBITDA reached $54 million, and management maintained full-year guidance despite softer demand.

JELD-WEN Holding Inc

TradingKey

Wed, Nov 4

Transcripts

Intrepid Potash (IPI) Q3 2026 Earnings Call: Trio Output and Guidance Rise

Intrepid Potash Q3 2026 earnings call: net income rose to $1.7 million, Trio output increased 19%, and management raised production and CapEx guidance.

Intrepid Potash Inc

TradingKey

Wed, Nov 4

Transcripts

Havertys (HVT) Q3 2026 Earnings Call: Sales Growth and Higher Margin Guidance

Havertys Q3 2026 earnings call: sales rose 4.5%, gross margin reached 62.3%, EPS increased to $0.39, and 2026 margin guidance was raised.

Haverty Furniture Companies Inc

TradingKey

Wed, Nov 4

Transcripts

GeoPark (GPRK) Q3 2026 Earnings Call: Bare Block and Vaca Muerta Growth

GeoPark’s Q3 2026 earnings call covered 3% production growth, $45.8 million adjusted EBITDA, higher costs, Venezuela’s Bare Block and Vaca Muerta expansion.

TradingKey

Wed, Nov 4

Transcripts

Ferroglobe (GSM) Q3 2026 Earnings Call: $100 Million Cost Plan

Ferroglobe Q3 2026 earnings call: revenue fell 2% to $370 million, adjusted EBITDA was negative $2 million, and management outlined a $100 million cost plan.

TradingKey

Wed, Nov 4

Transcripts

L.B. Foster (FSTR) Q3 2026 Earnings Call: Sales Rise 21.5%, Guidance Raised

L.B. Foster Q3 2026 sales rose 21.5% to $168 million, adjusted EBITDA reached $13.1 million, and management raised sales and cash flow guidance.

TradingKey

Wed, Nov 4

Earnings

Energy Fuels Q3 2026 Earnings: Revenue Rises, but Securities Loss Deepens Net Loss

Energy Fuels’ Q3 2026 revenue rose about 65% year over year to $29.2 million, led by uranium sales, while diluted loss per share widened to $0.20 from $0.07. Net loss attributable to the company reached $52.2 million, primarily because higher interest rates produced a non-cash unrealized loss on its marketable-securities portfolio. The uranium segment remained profitable for a third consecutive quarter, and the completed ASM acquisition added commercial-scale rare-earth metal and alloy capabilities through the Korean Metals Plant.

TradingKey

Wed, Nov 4

Transcripts

CMTG Q3 2026 Earnings Call: Deleveraging and Watchlist Reductions

CMTG’s Q3 2026 earnings call covered a $0.10 GAAP loss per share, $702 million of resolutions, lower leverage, watchlist reductions and REO sales.

Claros Mortgage Trust Inc

TradingKey

Wed, Nov 4

Transcripts

Community Healthcare Trust (CHCT) Q3 2026 Earnings Call: FFO Rises as Occupancy Improves

Community Healthcare Trust Q3 2026 revenue rose 4.4% to $32.4 million, FFO reached $0.54 per share, and occupancy improved to 90.1%.

Community Healthcare Trust Inc

TradingKey

Wed, Nov 4

Transcripts

BlueLinx (BXC) Q3 2026 Earnings Call: Sales Growth, Margin Expansion and Q4 Outlook

BlueLinx Q3 2026 earnings call: sales rose 8.5% to $813 million, adjusted EBITDA increased 42%, margins expanded, and Q4 volumes are expected to soften.

Bluelinx Holdings Inc

TradingKey

Wed, Nov 4

Transcripts

Aquestive Therapeutics (AQST) Q3 2026 Earnings Call: Anaphylm FDA Review and $90.3M Cash

Aquestive Therapeutics Q3 2026 earnings call: Anaphylm awaits a March 2027 FDA decision, cash reached $90.3 million, and guidance was maintained.

Aquestive Therapeutics Inc

TradingKey

Wed, Nov 4

Transcripts

The Andersons (ANDE) Q3 2026 Earnings Call: EPS Growth and $915 Million HLCP Deal

The Andersons (ANDE) Q3 2026 earnings call: adjusted EPS rose to $1.38, EBITDA reached $101 million, and the company announced a $915 million acquisition.

TradingKey

Wed, Nov 4

Transcripts

Advantage Solutions (ADV) Q3 2026 Earnings Call: $25M Restructuring Plan

Advantage Solutions’ Q3 2026 earnings call covers $782 million in revenue, $85 million in adjusted EBITDA, restructuring savings and reaffirmed guidance.

Advantage Solutions Inc

TradingKey

Wed, Nov 4

Transcripts

Westlake Chemical Partners (WLKP) Q3 2026 Earnings Call: Cash Flow and Coverage Improve

Westlake Chemical Partners’ Q3 2026 earnings call covered $16 million in net income, $18 million in cash flow, 1.09x coverage and its 2027 outlook.

TradingKey

Wed, Nov 4

Transcripts

Trinity Capital (TRIN) Q3 2026 Earnings Call: NII Covers Dividend, NAV Reaches $1.3 Billion

Trinity Capital’s Q3 2026 earnings call covered $0.52 per share of NII, record $1.3 billion net assets, improving credit quality and expanding managed funds.

Trinity Capital Inc

TradingKey

Wed, Nov 4

Transcripts

Marriott Vacations Worldwide (VAC) Q3 2026 Earnings Call: Sales Rise 29%, Guidance Raised

Marriott Vacations Worldwide Q3 2026 contract sales rose 29% and adjusted EBITDA gained 27%, prompting higher full-year guidance despite hurricane costs.

Marriott Vacations Worldwide Corp

TradingKey

Wed, Nov 4

Transcripts

Viridian Therapeutics (VRDN) Q3 2026 Earnings Call: Lumvoa Revenue Reaches $24.7 Million

Viridian Therapeutics’ Q3 2026 earnings call covered $24.7 million in Lumvoa revenue, more than 100 patient starts, payer access and pipeline milestones.

Viridian Therapeutics Inc

TradingKey

Wed, Nov 4

Transcripts

UroGen Pharma (URGN) Q3 2026 Earnings Call: ZUSDURI Revenue Rises 35%

UroGen Pharma Q3 2026 revenue reached $89 million as ZUSDURI sales rose 35% sequentially. Management targets profitability and positive cash flow in Q4.

Urogen Pharma Ltd

TradingKey

Wed, Nov 4

1...163 164 165

165/500

166 167...500 

Featured Tools

marketing_marketsTitle

calendar_economicCalendar

Economic Calendar

search.intelligent.strategy

article_asider_weekly_report

Popular Instruments

link

Name

Price

Chg%

link

DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video

US October PPI Preview: Fed Rate Hike Expectations Rise, PPI May Be Key Variable; How Will US Stocks, Dollar, and Gold Move?

Gold Price Forecast: Gold Tumbles Below $3,900 as Trump Says No Need for Iran Deal; Can October PPI Spur a Rebound?

【US Pre-Market】Nvidia Rebounds Over 2%; Microsoft Falls Over 2% Amid Massive Global Outage; October PPI Due

Dow Jones futures fall amid Fed rate hike fears, Nvidia leadership shakeup, PPI data eyed

link

Cerebras Systems Ord Shs Class A (Proposed) Stock (CBRS) Moved Up by 12.05% on Nov 13: Drivers Behind the Movement

2 hours ago

Korea Electric Power Corp Stock (KEP) Moved Down by 8.58% on Nov 13: What Investors Need To Know

2 hours ago

Fabrinet Stock (FN) Moved Down by 7.54% on Nov 13: What Signal Does It Send?

2 hours ago

Airbnb Inc Stock (ABNB) Moved Up by 3.15% on Nov 13: A Full Analysis

3 hours ago

Bloom Energy Corp Stock (BE) Moved Down by 5.03% on Nov 13: What Investors Need To Know

3 hours ago